Similar Articles
391 Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma secondary to metabolic-dysfunction associated steatotic liver disease
392 Sorafenib plus transarterial chemoembolization vs sorafenib alone for patients with advanced hepatocellular carcinoma: A systematic review and meta-analysis
393 Impact of body mass index on adverse kidney events in diabetes mellitus patients: A systematic-review and meta-analysis
394 Fatty acid binding protein 5 is a novel therapeutic target for hepatocellular carcinoma
395 What are the changes in the hotspots and frontiers of microRNAs in hepatocellular carcinoma over the past decade?
396 Identification of the key genes and mechanisms associated with transcatheter arterial chemoembolisation refractoriness in hepatocellular carcinoma
397 Efficacy and safety of Yangxue Qingnao Granules in treatment of migraine: A systematic review and meta-analysis
398 Application of neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy in curative surgery for esophageal cancer: A meta-analysis
399 Comparative study between Embosphere® and Marine gel® as embolic agents for chemoembolization of hepatocellular carcinoma
400 C-reactive protein to albumin ratio predict responses to programmed cell death-1 inhibitors in hepatocellular carcinoma patients
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA